You are here: Home / Publications / Presentations / Docs

Docs

 Title   Type 
What will happen to antimicrobial resistance in adult invasive pneumococcal disease after the introduction of infant PCV13 vaccination in Canada? File
Interactions between serotype and antimicrobial resistance in invasive pneumococcal disease in Canada File
Trends in antimicrobial resistance in Streptococcus pneumoniae, Canada, 1993-2009 File
Did the 2009 influenza pandemic change influenza prevention, diagnosis and management? Evidence from surveillance for influenza-associated hospitalisation in Canada File
Epidemiology and clinical features of severe influenza in adults: 7 years of surveillance in Toronto, Canada File
Factors associated with mortality in severe disease due to influenza in adults in Toronto, Canada, 2005-2008 File
Frequency of influenza causing hospital admission in a highly vaccinated adult population File
Prior use of fluoroquinolones (FQ), fluoroquinolone resistance and gyrA/parC mutations in Streptococcus pneumoniae (SPN) in Ontario File
Susceptibility to respiratory fluoroquinolones in Streptococcus pneumoniae in Toronto, Canada File
Re-establishment of susceptibility to respiratory fluoroquinolones (FQ) in Streptococcus pneumoniae in Toronto, Canada File
Interactions between serotype and mutations in quinolone-resistance determining regions of Streptococcus pneumoniae File
Prevalence of fluoroquinolone resistance and QRDR mutations in Streptococcus pneumoniae in Toronto, Canada, 1995-2006 File
Surveillance for antimicrobial resistance in Streptococcus pneumoniae in Canada, 1993–2011 File
Trends in serotypes causing invasive pneumococcal disease in Canadian adults, 2000-2009 File
Epidemiology of nosocomial invasive pneumococcal disease in Toronto, Canada, 1995-2007 File
Invasive pneumococcal disease in birth cohorts receiving PCV7 and PCV10 vaccine regimens in metropolitan Toronto and Peel Region, 2008-2010 File
Evolution of paediatric invasive pneumococcal disease (IPD) after implementation of a routine infant 13-valent pneumococcal conjugate vaccination program File
Risk factors for macrolide-resistance in pneumococcal bacteremia in Toronto, Canada File
Lack of impact of infant PCV vaccination on rates of adult invasive pneumococcal disease in Ontario, Canada File
Early impact of PCV10/PCV13 vaccine program on invasive pneumococcal disease (IPD) in Toronto, Canada File
Sero-epidemiology of pneumococcal pneumonia and invasive pneumococcal disease in adults in Ontario, Canada, 2000-2010 File
Genomic dissection of emergent multi-drug resistant (MDR) serotype 19A Streptococcus pneumoniae (SPN) File
Vaccine escape of Streptococcus pneumoniae (SPN) is coupled to amoxicillin resistance (AMOXR) in Canada File
Lack of emergence of gyrA Mutant Streptococcus pneumoniae (SP) isolates despite increased fluoroquinolones (FQ) usage File
Emergence of serotype 19A multi-drug resistant Streptococcus pneumoniae (MDR SPN) in Canada File
Invasive pneumococcal disease trends in those older than 65. Toronto, Ontario 1995-2006 File
Activities of cethromycin (CETH), ceftaroline (CPT), and ceftobiprole (BPR) against multi-drug resistant (MDR) Streptococcus pneumoniae (SP) isolates from Canadian Bacterial Surveillance Network (CBSN) File
Intravenous immunoglobulin for group A streptococcal toxic shock syndrome: A reassessment of efficacy File
A 13-year review of Streptococcus pneumoniae meningitis in children File
Impact of 7-valent pneumococcal conjugate vaccine (PCV7) on invasive pneumococcal disease (IPD) in children in Toronto and Peel Regions, Ontario, Canada File
A comparison of clinical features and outcomes of hospitalization due to seasonal and pandemic influenza A (H1N1) File
What does antibiotic history tell you about antibiotic resistance? – The relationship between prior macrolide and fluoroquinolone use and resistance in Streptococcus pneumoniae File
Risk factors for invasive infection with fluoroquinolone resistant Streptococcus pneumoniae and failure of oral outpatient fluoroquinolone therapy File
Serotype-specific trends in population based surveillance for invasive and respiratory pneumococcal disease in adults, Toronto, 2000-2010 File
Pneumococcal empyema in Toronto, Canada (1995-2006) File
Impact of antibiotic therapy on outcome of bacteremic pneumococcal pneumonia in Toronto, Canada File
Invasive pneumococcal disease in homeless adults in Toronto: Five years of population-based surveillance File
Epidemiology of severe infection due to influenza A (H1N1) and A (H3N2): Are there differences? File
Lack of emergence of fluoroquinolone (FQ resistance and gyrA mutations in Streptococcus pneumoniae (SP) despite increased FQ use File
Streptococcus pneumoniae serotypes in Ontario, Canada: Results from the Canadian Bacterial Surveillance Network File